Detalles de la búsqueda
1.
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.
Blood
; 140(26): 2773-2787, 2022 12 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36126318
2.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica
; 2024 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572549
3.
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Hematol Oncol
; 42(1): e3240, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38050405
4.
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA).
Haematologica
; 108(1): 22-33, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35545919
5.
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA.
Blood
; 139(10): 1588-1592, 2022 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34748627
6.
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38388854
7.
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Infection
; 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38771466
8.
High frequency of hyperglycaemia observed during CAR T-cell treatment.
Diabet Med
; 40(2): e14969, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36209376
9.
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.
Am J Hematol
; 97(8): E312-E317, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35702878
10.
Non-small-cell lung cancer infiltrated with chronic myelomonocytic leukaemia: a molecular diagnostic challenge to recognise mixed cancers in a single biopsy.
Histopathology
; 78(7): 1043-1046, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33410163
11.
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma.
Blood Cancer J
; 14(1): 41, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38448432
12.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma
; 65(2): 199-208, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966980
13.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine
; 71: 102553, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38533127
14.
Semi-automated 18F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation.
Comput Struct Biotechnol J
; 21: 1102-1114, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36789266
15.
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities.
JCO Oncol Pract
; 19(3): e407-e416, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36508702
16.
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities.
Cancers (Basel)
; 15(22)2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001703
17.
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study.
EClinicalMedicine
; 61: 102040, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37337616
18.
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands.
Cancers (Basel)
; 15(17)2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37686611
19.
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry.
Ther Adv Hematol
; 14: 20406207231154706, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36923264
20.
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Front Immunol
; 14: 1125030, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36911708